other benefits of glp-1 Surprising Medications Explained What Are GLP-1's? GLP-1's have

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Ready to lose weight and improve your quality of life

A clear comparison to help patients and professionals choose wisely.

Our teams combine advanced medical expertise with personal support to help you find the approach that fits your goals, your health needs and your lifestyle.

Current and pipeline incretin portfolio: GLP1, GLP1/GIP, GLP1/GRA, and amylincontaining combinations across SC and oral routes, with several Phase 23 agents aiming for ~2025% weight loss and cardiometabolic indications.